Molecular genetic testing of hemostasis and thrombosis in developing countries: achievements, hopes, and challenges.

In today's developing world, how do we define a "developing country"? What level of effort and resources is invested in diagnosis, patient care, and research in those countries that we define to be developing? In particular, what is the situation with respect to molecular genetic testing in these countries? How much has been achieved to date, and what are the challenges to further achievements? This article describes the current status, challenges, and future hopes with respect to molecular genetic testing in hemostasis and thrombosis from the perspective of experts from three countries: Brazil, Colombia, and Iran. These individuals have lived and practiced genetic testing in their countries and have also had the experience to work and/or interact with the developed world to enable an appreciation of the difference.

[1]  K. Kosik,et al.  Genetic testing must recognize impact of bad news on recipient , 2008, Nature.

[2]  A. Llinás.  The role of synovectomy in the management of a target joint , 2008, Haemophilia : the official journal of the World Federation of Hemophilia.

[3]  J. Annichino-Bizzacchi,et al.  Low density lipoprotein receptor-related protein polymorphisms are not risk factors for venous thromboembolism. , 2008, Thrombosis research.

[4]  Z. Rahimi,et al.  Thrombophilic mutations among Southern Iranian patients with sickle cell disease: high prevalence of factor V Leiden , 2008, Journal of Thrombosis and Thrombolysis.

[5]  A. Fernandes,et al.  Increased Factor V Leiden frequency is associated with venous thrombotic events among young Brazilian patients , 2007, Journal of Thrombosis and Thrombolysis.

[6]  A. Hajifathali,et al.  Factor V mutations in Iranian patients with activated protein C resistance and venous thrombosis. , 2007, Thrombosis research.

[7]  M. Zago,et al.  Cytokine gene variants and venous thrombotic risk in the BRATROS (BRAZILIAN THROMBOSIS STUDY). , 2007, Thrombosis research.

[8]  K. Hedayat,et al.  Therapeutic abortion in Islam: contemporary views of Muslim Shiite scholars and effect of recent Iranian legislation , 2006, Journal of Medical Ethics.

[9]  Andrés Ruiz-Linares,et al.  Admixture dynamics in Hispanics: a shift in the nuclear genetic ancestry of a South American population isolate. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[10]  P. Mannucci,et al.  Genetic diagnosis of haemophilia and other inherited bleeding disorders , 2006, Haemophilia : the official journal of the World Federation of Hemophilia.

[11]  F. Rodeghiero,et al.  Epidemiology of von Willebrand disease in developing countries. , 2005, Seminars in thrombosis and hemostasis.

[12]  Flora Peyvandi,et al.  Carrier detection and prenatal diagnosis of hemophilia in developing countries. , 2005, Seminars in thrombosis and hemostasis.

[13]  P. Mannucci,et al.  Glanzmann thrombasthenia and Bernard-Soulier syndrome in south Iran. , 2005, Clinical and laboratory haematology.

[14]  A. Giraldo,et al.  [Detection mutations in the DNA mismatch repair genes of hMLH1 and hMSH2 genes in Colombian families with suspicion of hereditary non-polyposis colorectal carcinoma (Lynch syndrome)]. , 2005, Biomedica : revista del Instituto Nacional de Salud.

[15]  A. Giraldo,et al.  MLH1 and MSH2 Mutations in Colombian Families with Hereditary Nonpolyposis Colorectal Cancer (Lynch syndrome) – Description of Four Novel Mutations , 2005, Familial Cancer.

[16]  A. Giraldo.  Genetic Services in Colombia , 2004, Public Health Genomics.

[17]  A. Llinás,et al.  The target joint , 2004, Haemophilia : the official journal of the World Federation of Hemophilia.

[18]  P. Mannucci,et al.  Recessively inherited coagulation disorders. , 2004, Blood.

[19]  M. Karimi,et al.  Comparison of attitudes towards prenatal diagnosis and termination of pregnancy for haemophilia in Iran and Italy , 2004, Haemophilia : the official journal of the World Federation of Hemophilia.

[20]  B. Simões,et al.  Large DNA inversions, deletions, and TaqI site mutations in severe haemophilia A , 1994, Human Genetics.

[21]  A. Camargo,et al.  Collaborative research networks work. , 2003, The Journal of clinical investigation.

[22]  C. Antunes,et al.  Color and genomic ancestry in Brazilians , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[23]  P. Mannucci,et al.  Rare coagulation deficiencies , 2002, Haemophilia : the official journal of the World Federation of Hemophilia.

[24]  S. Bydlowski,et al.  Factor VIII gene inversions and polymorphisms in Brazilian patients with haemophilia A: carrier detection and prenatal diagnosis , 2001, Haemophilia : the official journal of the World Federation of Hemophilia.

[25]  P. Mannucci,et al.  Clinical manifestations and complications of childbirth and replacement therapy in 385 Iranian patients with type 3 von Willebrand disease , 2000, British journal of haematology.

[26]  E. Castilla,et al.  Consanguinity in South America: Demographic Aspects , 2000, Human Heredity.

[27]  D. A. Palmieri,et al.  The genome sequence of the plant pathogen Xylella fastidiosa , 2000, Nature.

[28]  V. Arruda,et al.  Identification of one novel and three other point mutations in the protein C gene of five unrelated brazilian patients with hereditary protein C deficiency. , 2000, Haematologica.

[29]  V. Arruda,et al.  A Novel Splice Site Mutation in a Brazilian Patient with Hereditary Antithrombin Deficiency Type I , 1999, Human Heredity.

[30]  V. Arruda,et al.  A Novel Nonsense Mutation 6, E – X in the Protein S Gene Causes Type I Deficiency , 1999, Human Heredity.

[31]  E. Thorland,et al.  Germline mutations in Peruvian patients with hemophilia B: Pattern of mutation in AmerIndians is similar to the putative endogenous germline pattern , 1998, Human mutation.

[32]  F F Costa,et al.  Prevalence of the Prothrombin Gene Variant (nt20210A) in Venous Thrombosis and Arterial Disease , 1997, Thrombosis and Haemostasis.

[33]  S. Florell,et al.  Inherited thrombotic disorders: An update , 1997, American journal of hematology.

[34]  P. Reitsma,et al.  A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. , 1996, Blood.

[35]  D. Lourenço,et al.  [Antithrombin III dosage using the chromogenic substrate Tos-Gly-Pro-Arg-NAN, in several pathological situations]. , 1995, Revista da Associacao Medica Brasileira.

[36]  P. Reitsma,et al.  Eleven novel mutations in the factor VIII gene from Brazilian hemophilia A patients. , 1995, Blood.

[37]  P. Reitsma,et al.  Factor V Leiden (FVQ 506) is common in a Brazilian population , 1995, American journal of hematology.

[38]  E. Tuddenham,et al.  A Standard Nomenclature for Factor VIII and Factor IX Gene Mutations and Associated Amino Acid Alterations , 1994, Thrombosis and Haemostasis.

[39]  M. Zago,et al.  Factor IX gene haplotypes in Brazilian Blacks and characterization of unusual Ddel alleles , 1994, British journal of haematology.

[40]  M. S. Figueiredo,et al.  Analysis of factor VIII gene polymorphisms in Brazilian blacks reveals further differences in the black population. , 1994, Human heredity.

[41]  Pieter H. Reitsma,et al.  Mutation in blood coagulation factor V associated with resistance to activated protein C , 1994, Nature.

[42]  F. Costa,et al.  Factor VIII and IX Genes Polymorphisms in a Brazilian Black Population , 1993, Thrombosis and Haemostasis.

[43]  N. Morton,et al.  Genetic aspects of hemophilias A and B in Rio Grande do Sul, Brazil. , 1971, Human heredity.